Copyright
©The Author(s) 2019.
World J Clin Cases. Nov 6, 2019; 7(21): 3486-3504
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3486
Published online Nov 6, 2019. doi: 10.12998/wjcc.v7.i21.3486
Disease | No. | Title | Publication year | Academic organization | Category | Medical system |
Irritable bowel syndrome | 1 | American Gastroenterological Association medical position statement: Irritable bowel syndrome | 2002 | American Gastroenterological Association (AGA) | EB | WM |
2 | Guidelines on the irritable bowel syndrome: mechanisms and practical management | 2007 | British Society of Gastroenterology (BSG) | EB | WM | |
3 | Asian consensus on irritable bowel syndrome | 2010 | Asian Neurogastroenterology and Motility Association (ANMA) | EB | WM | |
4 | Diagnosis and treatment consensus on irritable bowel syndrome with traditional Chinese medicine | 2010 | China Society of Digestive Diseases in Chinese Medicine | CB | TCM | |
5 | Irritable bowel syndrome--the main recommendations | 2011 | German Society for Digestive and Metabolic Diseases (DGVS) German Society for Neurogastroenterology and Motility (DGNM) | EB | WM | |
6 | Consensus on irritable bowel syndrome by integrative medicine | 2011 | Speciality Committee of Digestive Diseases, Chinese Association of Integrative Medicine (CAIM) | CB-EB | IM | |
7 | American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome | 2014 | American Gastroenterological Association (AGA) | EB | WM | |
8 | Evidence-based clinical practice guidelines for irritable bowel syndrome | 2015 | Japanese Society of Gastroenterology (JSGE) | EB | WM | |
9 | Irritable bowel syndrome: a global perspective | 2015 | World Gastroenterology Organisation (WGO) | CB-EB | WM | |
10 | Irritable bowel syndrome in adults: diagnosis and management | 2015 | National Collaborating Centre for Nursing and Supportive Care (NICE) | CB-EB | WM | |
11 | Expert consensus on irritable bowel syndrome in China | 2016 | Chinese Society of Gastroenterology (CSGE) | EB | WM | |
12 | Danish national guideline: Diagnosis and treatment of irritable bowel syndrome | 2017 | Danish Society for Gastroenterology and Hepatology (DSGH) | EB | WM | |
13 | Diagnosis and treatment consensus on irritable bowel syndrome with traditional Chinese medicine (2017) | 2017 | China Society of Digestive Diseases in Chinese Medicine | CB | TCM | |
14 | The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: Consensus statements | 2017 | Multidisciplinary group of clinicians | CB-EB | WM | |
15 | Diagnosis and treatment consensus on irritable bowel syndrome with integrative medicine (2017) | 2017 | Speciality Committee of Digestive Diseases, Chinese Association of Integrative Medicine (CAIM) | CB | IM | |
16 | Clinical practice guidelines for irritable bowel syndrome in Korea, 2017 revised edition | 2018 | Korean Society of Neurogastroenterology and Motility (KSNM) | EB | WM | |
Functional constipation | 1 | Diagnosis and treatment consensus on functional constipation with traditional Chinese medicine | 2011 | China Society of Digestive Diseases in Chinese Medicine | CB | TCM |
2 | World Gastroenterology Organisation global guideline constipation - a global perspective | 2011 | World Gastroenterology Organisation (WGO) | CB-EB | WM | |
3 | Consensus statement AIGO/SICCR: Diagnosis and treatment of chronic constipation and obstructed defecation | 2012 | Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Colo-Rectal Surgery (SICCR) | EB | WM | |
4 | American Gastroenterological Association medical position statement on constipation | 2013 | American Gastroenterological Association medical (AGA) | EB | WM | |
5 | Diagnosis and treatment guideline of chronic constipation in China | 2013 | Gastrointestinal Motility Group of Digestive Disease Branch and Colorecatal Group of Surgery Branch of Chinese Medical Association | CB-EB | WM | |
6 | Guideline for the diagnosis and treatment of chronic functional constipation in Korea, 2015 revised edition | 2016 | Korean Society of Neurogastroenterology and Motility (KSNM) | EB | WM | |
7 | Diagnosis and treatment expert consensus on chronic constipation with traditional Chinese medicine (2017) | 2017 | China Association of Chinese Medicine (CACM) | CB | TCM | |
8 | Diagnosis and treatment consensus on chronic constipation with integrative medicine | 2018 | Chinese Association of Integrative Medicine (CAIM) | CB | IM | |
9 | Clinical practice guidelines from the French National Society of Coloproctology in treating chronic constipation | 2018 | French National Society of Coloproctology (SNFCP) | EB | WM | |
10 | Indian consensus on chronic constipation in adults: A joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of Gastroenterology | 2018 | Indian Motility and Functional Diseases Association, Indian Society of Gastroenterology | EB | WM | |
Both | 1 | Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment | 2007 | Canadian Association of Gastroenterology (CAG) | EB | WM |
2 | Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine: Diseases of modern medicine | 2008 | China Association of Chinese Medicine (CACM) | CB | TCM | |
3 | American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation | 2014 | American College of Gastroenterology (ACG) | EB | WM | |
4 | Clinical practice guideline: Irritable bowel syndrome with constipation and functional constipation in the adult | 2016 | Sociedad Española de Patología Digestiva (SEPD), Sociedad Española de Medicina de Familia y Comunitaria (semFYC), Sociedad Española de Médicos de Atención Primaria (SEMERGEN) and Sociedad Española de Médicos Generales y de Familia (SEMG) | EB | WM |
Drugs | Recommendations by CPGs | |
Pain | Antispasmodics | Strongly recommended or recommended by 13 CPGs; weak evidence reported by 1 CPG |
Peppermint oil | Strongly recommended or recommended by 4 CPGs | |
TCAs1 | Strongly recommended or recommended by 10 CPGs; weak evidence reported by 3 CPG | |
SSRIs | Strongly recommended or recommended by 10 CPGs; weak evidence reported by 3 CPG | |
Diarrhea | Loperamide | Recommended by 9 CPGs; weak evidence reported by 3 CPG |
Alosetron2 | Strongly recommended or recommended by 7 CPGs | |
Eluxadoline | Strongly recommended by 1 CPG; insufficient evidence reported by 1 CPG | |
Constipation | Mosapride | Recommended by 1 CPG |
Prucalopride | Insufficient evidence reported by 5 CPGs | |
PEG | Recommended by 6 CPGs; weak evidence reported by 1 CPG; insufficient evidence reported by 7 CPGs3 | |
Linaclotide | Strongly recommended or recommended by 7 CPGs | |
Lubiprostone | Strongly recommended by 6 CPGs; insufficient evidence reported by 1 CPG | |
Global symptoms | Probiotics | Strongly recommended or recommended by 6 CPGs; weak or insufficient evidence reported by 5 CPG |
Rifaximin | Recommended by 6 CPGs; weak or insufficient evidence reported by 5 CPG |
Category | Drugs | Recommendations by CPGs |
Bulking agents | Psyllium | Strongly recommended or recommended by 10 CPGs |
Bran | Recommended by 2 CPGs, insufficient evidence reported by 6 CPGs | |
Stool softeners | Docusate sodium | Insufficient evidence reported by 4 CPGs |
Liquid paraffin | Insufficient evidence reported by 4 CPGs | |
Glycerin | Insufficient evidence reported by 4 CPGs | |
Osmotic laxatives | PEG | Strongly recommended or recommended by 10 CPGs |
Lactulose | Recommended by 10 CPGs | |
Magnesium salts | Recommended by 1 CPG, insufficient evidence reported by 2 CPGs | |
Stimulant laxatives | Bisacodyl | Recommended by 9 CPGs, weak evidence reported by 1 CPG, insufficient evidence reported by 1 CPG |
Sodium picosulfate | Recommended by 9 CPGs, weak evidence reported by 1 CPG, insufficient evidence reported by 1 CPG | |
Senna | Insufficient evidence reported by 6 CPGs | |
Prosecretory agents | Lubiprostone | Strongly recommended or recommended by 7 CPGs |
Linaclotide | Strongly recommended or recommended by 7 CPGs | |
Others | Prucalopride | Strongly recommended or recommended by 9 CPGs |
Probiotics | Insufficient evidence reported by 6 CPGs | |
Enema and suppositories | Weak evidence reported by 6 CPGs, Strongly recommended by 1 CPG (CO2-releasing suppositories for distal constipation) |
Title | IBS-D | IBS-C | IBS-M | |||||||||
A | B | C | D | E | F | G | H | I | J | K | L | |
Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine: diseases of modern medicine: irritable bowel disease | ||||||||||||
* | * | * | * | * | * | |||||||
Diagnosis and treatment consensus on irritable bowel syndrome with traditional Chinese medicine | ||||||||||||
* | * | * | * | * | * | |||||||
Consensus on irritable bowel syndrome by integrative medicine | ||||||||||||
* | * | * | * | * | ||||||||
Diagnosis and treatment consensus on irritable bowel syndrome with traditional Chinese medicine (2017) | ||||||||||||
* | * | * | * | * | * | * | * | * | * | |||
Diagnosis and treatment consensus on irritable bowel syndrome with integrative medicine (2017) | ||||||||||||
* | * | * | * | * | * | * |
Title | FC | ||||||
A | B | C | D | E | F | G | |
Guidelines for diagnosis and treatment of common internal diseases in Chinese medicine: diseases of modern medicine: functional constipation | * | * | * | * | * | ||
Diagnosis and treatment consensus on functional constipation with traditional Chinese medicine | * | * | * | * | * | ||
Diagnosis and treatment expert consensus on chronic constipation with traditional Chinese medicine (2017) | * | * | * | * | * | * | * |
Diagnosis and treatment consensus on chronic constipation with integrative medicine | * | * | * | * | * | * | * |
Pattern | Formula | Patent medicine | |
IBS-D | A | Tongxieyao formula and Sini powder | - |
B | Shenlingbaizhu powder | Shenlingbaizhu granules | |
C | Fuzilizhong decoction and Sishen pills | Gubenyichang tablets, Bupiyichang pills and Sishen pills | |
D | Gegengqinlian decoction | Gegengqinlian micro pills | |
E | Shenlingbaizhu powder | Shenlingbaizhu granules | |
F | Wumei pills | - | |
IBS-C | G | Sini powder, Wumo decoction and Liumo decoction | Simo decoction oral liquid and Liuweinengxiao capsules |
H | Siwu decoction and Zengye decoction | Ziyinrunchang oral liquid | |
I | Maziren pills | Marenrunchang pills | |
J | Jichuan decoction | Qirongrunchang oral liquid | |
K | Huangqi decoction | - | |
IBS-M | L | Banxiaxiexin decoction Wumei pills | Wumei pills |
Pattern | Decoction | Patent medicine |
A | Maziren pills | Marenrunchang pills, Maren pills and Huanglianshangqing pills |
B | Liumo decoction | Muxiangliqi tablets, Zhishidaozhi pills, Muxiangbinlang pills and Simotang oral liquid |
C | Huangqi decoction | Bianmitong oral liquid and Qirongrunchang oral liquid |
D | Jichuan decoction | Banliu pills and Congrongtongbian oral liquid |
E | Zenye decoction | Tongle granules |
F | Runchang pills | Wurenrunchang pills |
- Citation: Dai L, Zhong LL, Ji G. Irritable bowel syndrome and functional constipation management with integrative medicine: A systematic review. World J Clin Cases 2019; 7(21): 3486-3504
- URL: https://www.wjgnet.com/2307-8960/full/v7/i21/3486.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i21.3486